Related references
Note: Only part of the references are listed.Deptor: not only a mTOR inhibitor
Valeria Catena et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Plasma cell maturity as a predictor of prognosis in multiple myeloma
Noriyoshi Iriyama et al.
MEDICAL ONCOLOGY (2016)
Endoplasmic Reticulum Stress in Immunity
Sarah E. Bettigole et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
The forkhead transcription factor FOXP1 represses human plasma cell differentiation
Martine van Keimpema et al.
BLOOD (2015)
Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia
Rajesh Somasundaram et al.
BLOOD (2015)
mTOR links environmental signals to T cell fate decisions
Nicole M. Chapman et al.
FRONTIERS IN IMMUNOLOGY (2015)
DEPTOR Is a Stemness Factor That Regulates Pluripotency of Embryonic Stem Cells
Pooja Agrawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target
N. I. Herath et al.
BLOOD CANCER JOURNAL (2014)
Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
Chungyee Leung-Hagesteijn et al.
CANCER CELL (2013)
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication
Irena Misiewicz-Krzeminska et al.
HAEMATOLOGICA (2013)
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Jan Budczies et al.
PLOS ONE (2012)
An Evolving Role for DEPTOR in Tumor Development and Progression
Zhiwei Wang et al.
NEOPLASIA (2012)
Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation and loss of marginal zone B cells
Sandrine Benhamron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Characterization of a Transitional Preplasmablast Population in the Process of Human B Cell to Plasma Cell Differentiation
Michel Jourdan et al.
JOURNAL OF IMMUNOLOGY (2011)
The genetic network controlling plasma cell differentiation
Stephen L. Nutt et al.
SEMINARS IN IMMUNOLOGY (2011)
The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
Jonathan D. Powell et al.
IMMUNITY (2010)
Biogenesis of secretory organelles during B cell differentiation
Semra J. Kirk et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
N. C. Gutierrez et al.
LEUKEMIA (2010)
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma
Kevin D. Boyd et al.
LEUKEMIA & LYMPHOMA (2010)
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti et al.
BLOOD (2009)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
J. Familiades et al.
LEUKEMIA (2009)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin
L. Laurenti et al.
LEUKEMIA (2007)
c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma
Hong Chang et al.
LEUKEMIA (2007)
Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia:: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals
N. C. Gutierrez et al.
LEUKEMIA (2007)
Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease
Luigia Lombardi et al.
GENES CHROMOSOMES & CANCER (2007)
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Ulf Klein et al.
NATURE IMMUNOLOGY (2006)
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
DR Carrasco et al.
CANCER CELL (2006)
The maturation of myeloma cells correlates with sensitivity to chemotherapeutic agents
Y Kuroda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
EM Hurt et al.
CANCER CELL (2004)
MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation
N Fujita et al.
CELL (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Stressed-out B cells? Plasma-cell differentiation and the unfolded protein response
JN Gass et al.
TRENDS IN IMMUNOLOGY (2004)
Reversion of B cell commitment upon loss of Pax5 expression
I Mikkola et al.
SCIENCE (2002)
Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program
AL Shaffer et al.
IMMUNITY (2002)
Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability
JE Ferrell
CURRENT OPINION IN CELL BIOLOGY (2002)
Share Paper
